Support and Exhibition Invitation for the Industry

Transcription

1 The 5 th World Congress on CONTROVERSIES IN OPHTHALMOLOGY Anterior Segment Glaucoma Retina March 20-23, 2014 Lisbon, Portugal Support and Exhibition Last Update: June 1 st, cophy@comtecmed.com

2 INVITATION FOR THE INDUSTRY We are pleased to announce the 5 th World Congress on Controversies in Ophthalmology (COPHy), which will take place in Lisbon, Portugal, March 20-23, The highly successful 1 st, 2 nd, 3 rd and 4 th COPHy Congresses, which took place in Prague, Barcelona, Istanbul and Budapest respectively, attracted over 2,600 participants from 60 countries. Based on the success of the past COPHy congresses, and on the feedback from the participants, COPHy Lisbon will be devoted to evidence-based debates and discussions amongst chairpersons, speakers and the audience, all of whom will examine and analyze the most relevant issues raised during the course of 2013 within the field of Ophthalmology. In 2014 we will continue to emphasis Retina, Anterior Segment and Glaucoma sections, and we will also discuss at large burning issues in Ophthalmology. We invite you to participate in the 5th World Congress of Controversies in Ophthalmology (COPHy), the next edition of many future congresses to come. As always, there are several opportunities and industry sponsored activities available and we would be happy to tailor a package to your needs. We look forward to seeing you in the beautiful city of Lisbon, a city with cultural diversity that fits exactly to our COPHy program. Sincerely, Prof. Neil Bressler Prof. Anat Loewenstein Co-Chairpersons Co-Chairpersons N. Bressler, USA A. Loewenstein, Israel Section Heads Anterior Segment J. Alio, Spain E. Assia, Israel W.J. Stark, USA Retina (including Uveitis, Tumors & Trauma) F. Bandello, Italy S. Bressler, USA W. Mieler, USA J. Moisseiev, Israel Glaucoma A. Heijl, Sweden J. Katz, USA Neuro-ophthalmology N. Miller, USA 2

3 CONGRESS PROFILE Since its launch in 2010, COPHy is establishing itself as a unique educational meeting where physicians can meet with outstanding experts in major Ophthalmology fields, and be updated on the most pressing clinical questions of the day. COPHy is the only annual congress of its kind that focuses mainly on controversial issues. Aims of the Congress To promote excellence in the field of Ophthalmology To provide an effective forum for discussing and debating unsolved issues by allowing ample time for speakers/audience discussion To promulgate ethics and standards of practice and treatment To bridge gaps between expansion of basic science and information, and their consolidation into clinical practice To make it possible for the industry to meet with outstanding experts in the field, and to update international participants on pressing clinical and technological questions of the day PAST CONGRESS STATISTICS COPHy Sessions 26 (including 3 symposia) 26 (including 2 symposia) 26 (including 5 symposia) 23 (including 5 symposia) Debates Faculty Poster Presentations Countries Demographics The 1 st COPHy Congress Prague, Czech Republic, March 4-7, 2010 The 2 nd COPHy Congress Barcelona, Spain, March 3-6, 2011 Eastern Europe 19% Latin America 0.5% North America 7.5% Africa 0.5% Asia Pacific 2.5% Middle East 28.5% Eastern Europe 12% Latin America 1.5% North America 8% Africa 0.5% Asia Pacific 1.5% Middle East 17.5% Western Europe 41.5% Western Europe 59% The 3 rd COPHy Congress Istanbul, Turkey, March 22-25, 2012 The 4 th COPHy Congress Budapest, Hungary, April 4-7, 2013 Eastern Europe 13.5% Latin America 0.5% North America 4% Asia Pacific 2% Middle East 27% Eastern Europe 19.5% Latin America 1.5% North America 7% Africa 3% Asia Pacific 4.5% Middle East 12% Western Europe 53% Western Europe 45,5% 3

4 PRELIMINARY LIST OF TOPICS MEDICAL RETINA Age-related macular degeneration: Nutritional supplements AREDS 2 results and their implication The role of Omega 3 Age-related macular degeneration - Aspirin The significance of AMD increased risk in patients taking Aspirin Age-related macular degeneration: Drug of choice Aflibercept (Eylea) Bevacizumab (Avastin) Ranibizumab (Lucentis) Age-related macular degeneration: Frequency of treatment PRN (e.g. as needed or treat and extend) Fixed frequency (e.g. monthly or every other month) First year vs. subsequent years Behcet s disease treatment Immunosuppression? Which biological agents? Local versus systemic therapy? Choroidal imaging: Is it necessary for diagnosis, prognosis, or treatment? Central serous chorioretinopathy: Management Focal leak: Prompt vs. deferred laser treatment Chronic diffuse leak: Observation? PDT full fluence? PDT half fluence? Diabetic macular edema: drug of choice and treatment regimen with centerinvolved edema and vision impairment in phakic patients Anti-VEGF with deferred or prompt laser? Aflibercept, bevacizumab, or ranibizumab? Monthly or DRCR Network algorithm or other algorithm? Laser followed by anti-vegf? DME Treatment regimen in pseudo phakic patients Anti-VEGF with deferred or prompt laser? Corticosteroids with deferred or prompt laser? Endophthalmitis prevention in intravitreal injections Topical antibiotics?: Before? After? Both? Povidoneiodine? Before? After? Both? Sterile gloves and drapes? Face mask? The risk of recurrent topical antiobiotic administration Should there be a different management in Anti VEGF injection vs. corticosteroid injection? Autofluorescence: Is it necessary for diagnosis, prognosis, or treatment management? Geographic atrophy? Choroidal neovascularization? Degenerative retinal diseases? Drug induced maculopathies? Laser in DME Non-center-involved DME? Standard or sub-threshold? Center-involved DME with excellent visual acuity (e.g., 20/20): Observe? Laser? Laser followed by anti-vegf? Anti-VEGF? Dietary supplements for age-related macular degeneration Intermediate stage of AMD? Early stage of AMD? Neovascular AMD? Family history and no AMD or only early stage of AMD? Lutein or zeaxanthin? Cigarette smokers? Gel caps or tablets? Role in geographic atrophy? Multifocal ERG: Is it necessary for diagnosis, prognosis, or treatment Retinitis pigmentosa: Current clinical management and future treatments Vitamins supplementation CME treatment Gene therapy Pharmacological treatment Neuroprotection Retinal implants Retinal transplant Management of Pseudophakic cystoid macular edema Topical NSAIDs (which one?), topical corticosteroids (which one?), or both? Role of subtenon s or intraocular corticosteroids Anti-VEGF in pseudophakic CME Retinal vein occlusion with macular edema Prompt treatment or observe for spontaneous improvement Corticosteroids or anti-vegf in phakic patients Corticosteroids or anti-vegf in pseudophakic patients Retinopathy of Prematurity Initiate treatment with anti-vegf therapy Laser Treatment Uveitis-related cystoid macular edema Intravitreal corticosteroids SubTenon s corticosteroids Anti-VEGF therapy Systemic immunosuppressive agents 4

5 PRELIMINARY LIST OF TOPICS CNV in inflammatory disease Anti VEGF alone? Steroids alone? Combination of anti VEGF and steroids? SURGICAL RETINA Brachytherapy for age-related macular degeneration Choroidal detachment post glaucoma surgery: Management Dyes in epiretinal membrane surgery Most cases? Which dyes? Vitreomacular traction Role of microplasmin Observation for progression Macular holes Role of microplasmin Role of head-down positioning Choice of gas Optic pit with serous retinal detachment Laser Vitrectomy Gas Management of macular schisis in pathologic myopia: Surgery or observation? Large submacular hemorrhage in predominantly hemorrhagic CNV lesion Anti-VEGF Vitrectomy Non-clearing vitreous hemorrhage: When to treat in: PDR AMD Vitrectomy for epiretinal membranes Role of microplasmin Peeling of ILM hole Lamellar macular holes ANTERIOR SEGMENT Femtosecond laser in cataract surgery Is it important and will it bring a significant change in our surgical results? Not important for the experiences high-volume cataract surgeon but could improve surgery for less capable surgeons Astigmatism correction: In low pre-op astigmatism How much astigmatism can we consider OK to leave postop- 0,25, 0.5, 0.75? How to correct low astigmatism? Femto LRIs? LRIs? OCCI? LASIK? Toric IOLs Posterior cornea and Toric IOL calculations Astigmatism shift with age: What is the best target for post op residual astigmatism? Can the astigmatism axis be rotated? Challenging cataract cases Posterior polar Cataract is a situation of a valve Traumatic cataract Keratoconus Cross linking - High energy beneficial? - Epithelium to be removed? Onlays Inlays Dislocated IOL s Removal Suturing to iris Suturing to sclera Scleral fixation without suturing Dry eye Medical treatment: How many times a day, when to occlude pungtum? Plugs Cyclosporine Surgery Lipiflow importance Osmolarity measurement importance IOL Calculations Normal eyes High myopia Short eyes Femto and IOL calculations LASIK in State of the art PRK Trans epitheliumvs removal of epithelium Multifocal / accommodative lenses AcrySofReSTOR ReZoom Oculentis Crystalens etc Special IOLs Aspheric Blue light blocking Telescopic IOL IOLs Different materials and brands (glistening/deposits/ stability/centration) 5

6 PRELIMINARY LIST OF TOPICS Phaco fluidics and power settings, technologies, machines Ozil technology Bimanual micro phacoemulsification Various machines: Infinity, Stellaris (dual linear), White Star, STAAR Pterygium surgery Stem cell transplantation in conjunctival disorders Penetrating Keratoplasty Conventional Femtosecond assist Pupillary dilation Iris hooks Pupil dilator Iris expander Premium IOL s Importance and indications Screening Pseudophakic presbyopia solution / general presbyopia correction Multifocal IOL Mini / moderate / conventional monovision Corneal inlays GLAUCOMA Laser to trabecular meshwork ALT SLT Blood flow and perfusion pressure in glaucoma ciliary body ablative procedures Diode laser Endolaser Cryo Coexisting cataract and glaucoma medical management: First line for open angle glaucoma Combination Monotherapy Which drug Treatment monitoring Continuous measurements Diurnal IOP measurements Future of glaucoma treatment Gene therapy Neuroprotection Stem cell therapy Nanotechnology Future of glaucoma surgery istent Trabectome Canaloplasty Laser assisted non penetrating deep scelrectomy Neovascular glaucoma Trabeculotomy with express shunt Tube shunt Perioperative anti-vegf Non-penetrating sclerectomy Conventional Laser assisted Optic nerve head imaging SD-OCT GDx HRT New ways to assess of the ganglion cell layer Pediatric glaucoma Goniotomy Trabeculotomy Shunt devices OTHER Choroidal melanoma Plaque Proton beam Intraocular lymphoma: Trends in therapy Systemic Intraocular MTX/ Rithuximab Radiation Pseudotumor cerebri: Management Surgical Medical Psuedotumor cerebri in pregnancy Acetazolamide? Steroids? Pediatric pseudotumor cerebri Retinoblastoma Periocular chemotherapy Systemic chemotherapy Posterior optic neuropathy: Evaluation and management Role of anti VEGF Steroids Management of isolated optic neuritis With MRI lesion Without MRI lesion 6

7 PRELIMINARY SCIENTIFIC TIMETABLE Subject to change 19:00 Welcome Reception Thursday, March 20, 2014 Friday, March 21, 2014 Hall A Hall B Hall C 08:30-10:00 Retina I Anterior Segment I Glaucoma I 10:00-10:30 Coffee Break 10:30-11:45 Industrial Satellite Symposium 11:45-13:15 Retina II Anterior Segment II Glaucoma II 13:15-14:15 Lunch Break and Visit Exhibits 14:15-15:45 Industrial Satellite Symposium 15:45-16:15 Coffee Break 16:15-17:45 Retina III Anterior Segment III Neuro-Ophthalmology I Saturday, March 22, 2014 Hall A Hall B Hall C 08:30-10:00 Retina IV Anterior Segment IV Glaucoma III 10:00-10:30 Coffee Break 10:30-11:45 Industrial Satellite Symposium 11:45-13:15 Retina V Trauma Uveitis 13:15-14:15 Lunch Break and Visit Exhibits 14:15-15:45 Industrial Satellite Symposium 15:45-16:15 Coffee Break 16:15-17:45 Retina VI Neuro-Ophthalmology II Sunday, March 23, 2014 Travel Day 7

8 LEVELs OF SUPPORT (Level determined by the accumulation of items of value) Presidential Circle (Limited to one supporter) 110,000 and up Platinum 85,000 Gold 60,000 Silver 40,000 Bronze 20,000 Contributor 3,000-19,000 CATEGORIES PRIORITES Presidential Circle category will have the priority in choosing up to two additional support items to the value of 20,000 Platinum category will have the priority in choosing up to two additional support items to the value of 15,000 Gold category will have the priority in choosing up to one additional support items to the value of 5,000 Special industrial symposia time slots will be allocated on a first-come, first-served basis. The company supporting a satellite symposium may select the speakers and topics. In addition to the sponsorship fee, the company must cover all speakers expenses, including registration, accommodation and travel expenses. This also applies in the case where the symposium speakers have already been invited by the Congress. The program of the satellite symposia are subject to approval by the scientific committee of the Congress. In case that the scientific committee rejects the program of a satellite symposium, each party will be entitled to cancel the satellite symposium without paying a penalty for the cancellation or for any damages caused by the cancellation to the other party. 8

9 EDUCATIONAL SUPPORT OPPORTUNITIES CONTINUING MEDICAL EDUCATION (CME) APPROVED SESSION 35,000 A company may provide a grant to support an existing session of particular interest to the company. Dates: Friday or Saturday. Grant includes expenses of session hall and basic audiovisual equipment Grant includes expenses of 5 Moderators, Chairs and Speakers during the session Company profile in the supporters' booklet One full page color advertisement in the supporters' booklet Acknowledgment: congress website, congress supporters' booklet, on-site Signage Company logo on regular announcements to congress database Exhibition space will be charged at a supporters' rate of 450 per sq.m Video or and audio webcast at special rates Recording of presentation to allow pod cast of session, to be available on the COPHy Website for up to a year at special rates CONTINUING MEDICAL EDUCATION (CME) APPROVED PRESENTATION 20,000 Opportunity to support an existing presentation or to suggest a presentation as part of a CME-approved session in the scientific program Session hall and basic audiovisual equipment Company profile in the supporters booklet One full page color advertisement in the supporters booklet Acknowledgment: congress website, congress program book, on-site signage Brochure in the participants' bags PROMOTIONAL SUPPORT OPPORTUNITIES BREAKFAST INDUSTRIAL SYMPOSIUM (NON-CME APPROVED) 40,000 A company may organize a Breakfast Industrial (non-cme approved) Symposium (60 minutes; from 7:15 AM to 8:15 AM). The topic will be subject to approval by the chairpersons of the congress (Profs. Bressler and Loewenstein) and is expected to follow the controversies theme of the congress. The speakers or moderators will be subject to the approval of the chairpersons so that they can be included in the scientific program as either speakers or moderators or both, and should be available for the entire duration of the Scientific Program (Friday, Saturday). Dates: Friday or Saturday. Symposium timeslot will be before any scientific sessions. A "Pre Served" breakfast will be available during the Symposium for all participants Symposium hall and basic audiovisual equipment Company profile in the supporters' booklet One full page color advertisement in the supporters' booklet Acknowledgment: congress website, congress program book, on-site signage Company logo on regular announcements to congress database Exhibition space will be charged at a supporters' rate of 450 per sq.m Video or and audio webcast at special rates Recording of presentation to allow pod cast of session, to be available on the COPHy Website for up to a year at special rates The expenses (travel, accommodation, honorarium and registration) of the chairpersons and speakers of the breakfast industrial symposium are additional and the responsibility of the supporter. 9

10 PROMOTIONAL SUPPORT OPPORTUNITIES PRE-LUNCH PLENARY INDUSTRIAL SYMPOSIUM (NON-CME APPROVED) 55,000 A company may organize an industrial non-cme approved symposium (60-90 minutes) prior to the lunch with no parallel scientific sessions. The topic will be subject to approval by the chairpersons of the congress (Profs. Bressler and Loewenstein) and is expected to follow the controversies theme of the congress. The speakers or moderators will be subject to the approval of the chairpersons so that they can be included in the Scientific Program as either speakers or moderators or both, and should be available for the entire duration of the scientific program (Friday, Saturday). Plenary symposium hall and basic audiovisual equipment Company profile in the supporters' booklet One full page color advertisement in the supporters' booklet Acknowledgment: congress website, congress supporters' booklet, on-site signage Company logo on regular announcements to congress database Exhibition space will be charged at a supporters' rate of 450 per sq.m Video or and audio webcast at special rates Recording of presentation to allow pod cast of session, to be available on the COPHy Website for up to a year at special rates The expenses (travel, accommodation and registration) of the chairpersons and speakers of the plenary industrial symposium are additional and the responsibility of the supporter. PLENARY INDUSTRIAL SYMPOSIUM LUNCH SYMPOSIUM (NON-CME APPROVED) 60,000 Limited to one company per day only, not including lunchboxes A company may organize an industrial non-cme approved symposium (60-90 minutes) during lunch with no parallel scientific sessions. The topic will be subject to approval by the chairpersons of the congress (Profs. Bressler and Loewenstein) and is expected to follow the controversies theme of the congress. The speakers or moderators will be subject to the approval of the chairpersons so that they can be included in the Scientific Program as either speakers or moderators or both, and should be available for the entire duration of the scientific program (Friday, Saturday). The symposium does not include the cost of the lunch box. This is optional and available at an additional cost Plenary symposium hall and basic audiovisual equipment Company profile in the supporters' booklet One full page color advertisement in the supporters' booklet Acknowledgment: congress website, congress program book, on-site signage Company logo on regular announcements to congress database Exhibition space will be charged at a sponsor rate of 450 per sq.m Video or and audio webcast at special rates Recording of presentation to allow pod cast of session, to be available on the COPHy Website for up to a year at special rates The expenses (travel, accommodation and registration) of the chairpersons and speakers of the industrial lunch symposium are additional and the responsibility of the supporter. 10

11 PROMOTIONAL SUPPORT OPPORTUNITIES POST-LUNCH PLENARY INDUSTRIAL SYMPOSIUM (NON-CME APPROVED) 50,000 A company may organize an industrial non-cme approved symposium (60-90 minutes) following the lunch with no parallel scientific sessions. The topic will be subject to approval by the chairpersons of the congress (Profs. Bressler and Loewenstein) and is expected to follow the controversies theme of the congress. The speakers or moderators will be subject to the approval of the chairpersons so that they can be included in the scientific program as either speakers or moderators or both, and should be available for the entire duration of the scientific program (Friday, Saturday).. Plenary Symposium hall and basic audiovisual equipment Company profile in the supporters' booklet One full page color advertisement in the supporters' booklet Acknowledgment: congress website, congress supporters' booklet, on-site signage Company logo on regular announcements to congress database Exhibition space will be charged at a supporters' rate of 450 per sq.m Video or and audio webcast at special rates Recording of presentation to allow pod cast of session, to be available on the COPHy Website for up to a year at special rates The expenses (travel, accommodation and registration) of the chairpersons and speakers of the plenary industrial symposium are additional and the responsibility of the supporter. NEW PLAYERS ON THE BLOCK 15,000 A company may provide an unrestricted grant for a presentation of minutes on a new drug/product to be included in the New Players session. Session hall and basic audiovisual equipment Company profile in the supporters' Booklet Acknowledgment: Congress Website, Congress supporters' Booklet, on-site Signage WELCOME RECEPTION Sole Support 10,000 Opportunity to support the welcome reception for all participants of the Congress. The reception will be held on Thursday evening. Company logo on the official invitation to the welcome reception Company profile in the supporters' Booklet One full page color advertisement in the supporters' Booklet Acknowledgment: Congress Website, Congress supporters' Booklet, on-site Signage FACULTY DINNER Sole Support 10,000 Opportunity to support the official dinner for all invited speakers of the Congress Company logo on the official invitation to the welcome reception Company profile in the Supporters' Booklet One full page color advertisement in the Supporters' Booklet Acknowledgment on special board on-site during the faculty dinner Acknowledgment: Congress Website, Congress supporters' Booklet, on-site Signage 11

12 PROMOTIONAL SUPPORT OPPORTUNITIES SUPPORTERS BOOKLET Sole Support 10,000 The sponsors booklet will include the profiles and advertisements of the Congress supporters. Also included in the booklet the updated exhibition map and list of exhibitiors. Company profile in the sponsors booklet Two full page color advertisement in the sponsors booklet (back cover and inside page) Acknowledgment: congress website, congress supporters' Booklet, on-site signage INTERNET AREA Sole Support 7,000 The Internet Area will be outfitted with internet workstations for participants to stay updated between sessions Display logo as a screen background Opportunity to provide branded mouse pads Company profile in the Supporters' booklet Acknowledgment: congress website, congress supporters' book, on-site signage PARTICIPANTS BAGS Sole Support provided-in-kind + 10,000 The opportunity to provide branded bags for all participants of the Congress, except where precluded by a participant s regional laws. This support opportunity is reserved for Presidential Circle, Platinum and Gold Supporters, and will be available on a first-come, first-served basis. Company profile in the Supporters' booklet Acknowledgment: congress website, congress supporters' book, on-site signage CONGRESS LANYARDS Sole Support provided-in-kind + 5,000 This opportunity is reserved for presidential circle and platinum supporters, and will be available on a firstcome, first-served basis. Opportunity to provide branded lanyards Acknowledgment: congress website, congress supporters' book, on-site signage NOTE PADS AND PENS Sole Support provided-in-kind + 5,000 Opportunity to provide branded note pads and pens to be distributed in the participants bags Company profile in the Supporters' booklet Acknowledgment: congress website, congress supporters' book, on-site signage BROCHURE INSERT 3,000 Company brochure to be inserted into the participants bags Company profile in the Supporters' booklet Acknowledgment: congress website, congress supporters' book, on-site signage COFFEE BREAK Opportunity to support, in part, a coffee break for all participants of the Congress Company profile in the congress program book Acknowledgment: congress website, congress supporters, on-site signage 2,000 (per coffee break) TAILOR-MADE SUPPORT PACKAGES Support packages may be tailored to suit the company s budget and interests and in order to maximize visibility, and to best promote products and services. Please contact the Congress Organizer for further details on creating the appropriate package. 12

13 EXHIBITION The exhibition will be held at the Congress venue. The exhibition floorplan is designed to maximize exposure to the participants. Lunches and coffee breaks will be held in the exhibition area. Exhibition space will be available on a first-come, first-served basis, with priority given to presidential circle and platinum supporters. Exhibition space will be available at 650 per sq.m. Companies that will contribute minimum of 25,000 will be entitled to a special supporters' rate of 450 per sq.m. The minimum booth size is 2x3 sq.m. Please visit the website at to view the exhibition floorplan. Exhibition space rental is priced according to size (per sq.m) and includes: Net stand area Company profile in Supporters' booklet Two exhibitor registrations (up to 18 sq.m, additional registration per 6 sq.m) Additional exhibitor registrations available for 250 per badge General cleaning of public areas Stand equipment and additional services may be ordered by means of the forms in the Supporters' manual on the website: Furniture, partition walls, carpets, telephone and data lines, electricity, stand cleaning, Supporters' insurance, logistics, etc. COPHy 2013 SPONSORS & EXHIBITIORS 13

14 Exhibition floorplan hall B COMTECMED OFFICE POSTER AREA MAIN ENTRANCE speakers preview room 3x2m 3x2m #11 #10 #9 5x2m hall A 3x2m 3x2m #8 #7 #6 5x2m hall C 3x2m #5 3x1m #4 6x1m #3 3x3m #2 #1 Maximum building height 3m 3x3m 14

15 GENERAL INFORMATION Venue EPIC SANA Lisboa Hotel Av. Engenheiro Duarte Pacheco Lisboa, Portugal Tel: Fax: info.lisboa@epic.sanahotels.com Language The official language of the Congress is English. Congress Organizer and Support / Exhibition Contact: 53, Rothschild Boulevard, PO Box 68 Tel Aviv, , Israel Tel: Fax: cophy@comtecmed.com Liability and Insurance The Congress Organizer cannot accept liability for personal accidents loss of or damage of private property of participants, either during or indirectly arising from the COPHy Congress. Participants are advised to issue their own personal travel and health insurance for their trip. Terms and Conditions Support items are allocated on a first-come, first-served basis All support and exhibition prices quoted are in and are subject to VAT All payments must be received before the beginning of the Congress. Should the company fail to make the payment prior to the commencement of the Congress, the Organizer saves the right to cancel the company s participation and benefits. Time slot allocation will be based on level of support and approval from the Organizing Committee It is the responsibility of the supporters and exhibitors to comply with the regulations of the local authorities, EFPIA (European Federation of Pharmaceutical Industries & Associations) and IFMPA (International Federation of Pharmaceutical Manufacturers & Associations) www. ifpma.org Code of Practice on the Promotion of Medicines. The Congress Organizer reserves the right to accept or decline offers of support and application for exhibition space The Congress Organizer reserves the right to amend the published floorplan should it be deemed necessary for the benefit of the exhibition and the Congress as a whole Please note that the Congress Organizer must approve all exhibition stand designs Hermes & Merkur is the sole logistic supplier for the COPHy 2014 Congress. All materials sent directly to the venue (not via our logistic agent AKA Hermes) will not be under COMTECMED's responsibility. We are not liable if the shipment does not arrive due to costumes clearness issues or any other delays that might occur. 15

16 The 5 th World Congress on CONTROVERSIES IN OPHTHALMOLOGY Anterior Segment Glaucoma Retina March 20-23, 2014 Lisbon, Portugal cophy@comtecmed.com